United Therapeutics and Citibank inks $250M agreement under ASR program

|About: United Therapeutics Corpor... (UTHR)|By:, SA News Editor

United Therapeutics (NASDAQ:UTHR) announces that it entered into an agreement with Citibank relating to a collared accelerated share repurchase (ASR) program under which the company will buy back $250M of its common stock.

The actual number of shares purchased will be determined at the completion of the ASR Program, expected in Q4.

The company will fund the transactions with $250M of borrowings under its revolving credit facility.

Subscribe for full text news in your inbox